# A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis

> **NCT01458574** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 593 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Placebo
- **DRUG:** CP690,550
- **DRUG:** CP-690,550

## Key facts

- **NCT ID:** NCT01458574
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-20
- **Primary completion:** 2016-05-27
- **Final completion:** 2016-05-27
- **Target enrollment:** 593 (ACTUAL)
- **Last updated:** 2017-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01458574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01458574, "A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01458574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*